JENNIFER DONOVAN: Open Payments
NPI 1205587086 · GREENBRAE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $39 |
| ABBVIE INC. | 1 | $32 |
| PFIZER INC. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Lilly USA, LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $14 |
Products named: JARDIANCE, Kerendia, Veozah, UBRELVY, NURTEC ODT, CAPLYTA, MOUNJARO, Rybelsus.
Industry payments across CA — which companies pay providers there.
